Impact of Digital Screen Time in Progression of Myopia in Children

June 28, 2025 updated by: Muhammad Naveed Babur, Superior University
Research suggests that prolonged digital screen time is a significant contributing factor to the progression of myopia in children. Studies have shown that increased near-work activities, such as reading, writing, and screen time, can lead to an increased risk of developing myopia. The widespread use of digital devices among children has raised concerns about the potential impact on their eye health.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

79

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Punjab
      • Lahore, Punjab, Pakistan
        • Watan optical

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Impact of Digital Screen Time in Progression of Myopia in Children he widespread use of digital devices among children has raised concerns about the potential impact on their eye health. Excessive screen time can cause prolonged near focus, reduced outdoor time, and increased blue light exposure, all of which may contribute to myopia progression.

Description

Inclusion Criteria:

  • Both male and female myopic children of age 6 to 12 years were included with BCVA 6/6 with no any eye pathology.
  • No medication or disease that could affect vision.
  • Spherical equivalent of cylinder 0.50 to 1.00 were added.

Exclusion Criteria:

  • Opacity, cataract, any fundus pathologies, strabismus or indication of previous ocular surgeries were excluded.
  • High astigmatic children were excluded or more than 1.00DC.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
self admistred questioner
Time Frame: 12 Months
self admistred questioner to check Mild, moderate, and severe Myopia in Children
12 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Superior University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 17, 2025

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

February 28, 2026

Study Registration Dates

First Submitted

June 28, 2025

First Submitted That Met QC Criteria

June 28, 2025

First Posted (Actual)

July 9, 2025

Study Record Updates

Last Update Posted (Actual)

July 9, 2025

Last Update Submitted That Met QC Criteria

June 28, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MSRSW/Batch-Fall23/831

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia, Progressive

Clinical Trials on Progression of Myopia

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe